TTA-A2
TTA-A2 is a potent and selective T-type calcium channel antagonist, showing high affinity for Cav3.1 and Cav3.2 isoforms. Its anticonvulsant properties make it a valuable research tool for studying neurological conditions such as epilepsy and sleep disorders in both in vitro and in vivo models.
Product Specifications
CAS Number
953778-63-7
Product Name Alternative
Cav3.1 (a1G), Cav3.2 (a1H), CalciumChannel, Calcium Channel, Ca2+ channels, Ca channels, Electrocorticogram, Epilepsy, Inhibitor, inhibit, neurological diseases, Pregnane X receptor, sleep disorders, T-type calcium channel, TTA A2, TTAA2, TTA-A2, TTA-A-2
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
98.95% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2 mg/mL (5.29 mM) ; DMSO:27.5 mg/mL (72.68 mM)
Smiles
C[C@@H] (NC (=O) Cc1ccc (cc1) C1CC1) c1ccc (OCC (F) (F) F) cn1
Molecular Formula
C20H21F3N2O2
Molecular Weight
378.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
44225121 3x 1.0µg DNA
SLC4A8 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
MBS1435191-01 0.02 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis ATP synthase subunit delta (atpH)
Sign In for Pricing
View Details MBS1435191-02 0.1 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis ATP synthase subunit delta (atpH)
Sign In for Pricing
View Details MBS1435191-03 0.02 mg (Yeast)
Recombinant Yersinia pseudotuberculosis ATP synthase subunit delta (atpH)
Sign In for Pricing
View Details